Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIENA: Steroids in Eosinophil Negative Asthma
NCT02066298Phase 3Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Jul 2014
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mometasone in asthma (6 arms), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoint: Pairwise Comparison of Treatments Based on Composite Measure Using Treatment Failures, Asthma Control Days, and Percent Predicted FEV1 at 12 weeks. Started Jul 2014; status: completed.
02
Drugs
mometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02066298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066298.